Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 USD | +18.64% | +26.83% | +68.28% |
05-15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
05-14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.28% | 44.31M | |
+51.85% | 59.28B | |
+41.42% | 40.94B | |
-5.25% | 40.17B | |
-5.16% | 28.69B | |
+12.79% | 26.63B | |
-20.18% | 18.89B | |
+30.88% | 12.46B | |
+0.61% | 12.42B | |
+25.06% | 12.26B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q3 2020 Earnings Call, Nov 12, 2020